While the functional significance of some of these mutations have been experimentally tested in vivo (Yu et al., 2013), results reported here further support that LATS1/2 act normally as tumor suppressors and loss of their functions contributes to human cancer development. This evidence concerns the gene LATS1 and neoplasm.